跳至主要内容
临床试验/IRCT20200513047427N1
IRCT20200513047427N1已完成3 期

Effect of nano-curcumin on radiotherapy-induced skin reaction in breast cancer patients: a randomized, triple-blind, placebo-controlled trial

Kashan University of Medical Sciences0 个研究点目标入组 42 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
已完成
入组人数
42

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 80 years(—)
性别
Female

入选标准

  • Breast cancer patients who will undergo radiotherapy.

排除标准

  • Patients whose breast region have previously been irradiated.
  • Patients with bilateral breast cancer.
  • Patients receiving concurrent chemotherapy and radiotherapy
  • Patients taking anticoagulants such as warfarin (Coumadin) or heparin
  • Patients with skin conditions (such as bleeding, ulcers or incurable wounds) or sensitivity to formulations
  • Patients treated by anti-epidermal growth factor (EGRF)
  • Patients undergoing minor radiation to the breast area
  • Patients with special skin allergies
  • Patients with diagnosis of inflammatory breast cancer and reconstructive treatment

研究者

相似试验